Edition:
India

Cytokinetics Inc (CYTK.OQ)

CYTK.OQ on NASDAQ Stock Exchange Global Select Market

13.00USD
20 Sep 2019
Change (% chg)

-- (--)
Prev Close
$13.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
156,687
52-wk High
$14.91
52-wk Low
$5.76

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 8.46 -0.536
FY 2018 Dec '18 9.38 -0.484
Sep '18 10.64 -0.403
Jun '18 6.22 -0.507
Mar '18 5.27 -0.560
FY 2017 Dec '17 -0.02 -0.750
Sep '17 6.18 -0.602
Jun '17 3.05 -0.603
Mar '17 4.15 -0.556
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 5 7.85 9.39 6.35 5.00
Quarter Ending Dec-19 5 9.49 14.08 7.50 5.25
Year Ending Dec-19 6 31.40 38.00 29.00 22.95
Year Ending Dec-20 6 32.36 39.00 27.00 35.90
Earnings (per share)
Quarter Ending Sep-19 5 -0.47 -0.45 -0.50 -0.52
Quarter Ending Dec-19 5 -0.42 -0.39 -0.45 -0.56
Year Ending Dec-19 6 -1.88 -1.56 -2.02 -2.07
Year Ending Dec-20 6 -1.83 -1.40 -2.07 -2.12
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 135.64 3.20 0.55
EPS (TTM) % 24.49 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cytokinetics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 7.91 4.91 99 --
13 Week 32.10 28.35 99 --
26 Week 72.20 51.65 99 --
52 Week 53.67 44.10 99 --
YTD 92.09 59.14 99 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 70.88%
# of Holders: 181
Total Shares Held: 40,913,726
3 Mo. Net Change: 139,315
# New Positions: 4
# Closed Positions: 4
# Increased Positions: 14
# Reduced Positions: 12
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.